|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03759 PHARMARON
Nominal 
13.000 -0.560 (-4.130%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Turnover | 5,604,463 | -0.632% | 5,640,118 | 4,634,585 | 3,285,511 | 2,193,167 |
| Cost of Sales | (3,756,412) | 4.267% | (3,602,677) | (3,021,474) | (2,095,800) | (1,398,767) |
| Gross Profit | 1,848,051 | -9.295% | 2,037,441 | 1,613,111 | 1,189,711 | 794,400 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (22,940) | 114.132% | (10,713) | (6,339) | 472 | (3,215) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (30,306) | -- | 10,982 | (4,439) | (6,993) | (20,824) | |
| Profit / (Loss) before Taxation | 1,226,851 | 35.038% | 908,525 | 742,698 | 665,910 | 532,299 | |
| Taxation | (143,905) | 15.626% | (124,457) | (177,398) | (118,610) | (65,664) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 30,457 | 1404.049% | 2,025 | 20,132 | 17,537 | 12,325 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 1,113,403 | 41.638% | 786,093 | 585,432 | 564,837 | 478,960 | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 87,373 | 16.821% | 74,792 | 57,933 | (4,098) | (29,757) |
| Depreciation & Amortisation | 554,813 | 15.181% | 481,689 | 340,423 | 269,291 | 205,551 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| EPS (cts) | 62.820 | 41.423% | 44.420 | 32.940 | 31.673 | 26.902 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 7.280 | -- | 6.345 | 5.573 | 5.240457 | 4.550742 |
| Remarks: | Real time quote last updated: 28/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,113,403 |
| %Change | 41.638% |
| EPS / (LPS) | RMB 0.628 |
| NBV Per Share (¥) | RMB 7.280 |